Journal of Clinical Oncology , 0732-183X

Journal

1 - 50 out of 120Page size: 50

Publications

  1. 2020
  2. E-pub ahead of print

    Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia

    Charles Craddock, Aimee Jackson, Justin Loke, Ram Malladi, Keith Wheatley & 7 others, , Naeem Khan & Sylvie Freeman, 29 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 12 p., JCO2002308.

    Research output: Contribution to journal › Article › peer-review

  3. E-pub ahead of print

    Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

    Sylvie Freeman, 23 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO2001170

    Research output: Contribution to journal › Article › peer-review

  4. E-pub ahead of print

    Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study

    Aneel Bhangu, 6 Oct 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . 14 p., JCO2001933.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    De-escalation after DE-ESCALATE and RTOG 1016: a head and neck cancer InterGroup framework for future de-escalation studies

    Hisham Mehanna, 1 Aug 2020, In: Journal of Clinical Oncology . 38, 22, p. 2552-2557 7 p.

    Research output: Contribution to journal › Article › peer-review

  6. E-pub ahead of print

    Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

    Daniel Rea, 24 Jul 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO1902427

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Less is not necessarily more: toward a rational selection of the conditioning regimen in acute myeloid leukemia

    Sylvie Freeman, 20 Apr 2020, In: Journal of Clinical Oncology . 38, 12, p. 1249-1251 3 p.

    Research output: Contribution to journal › Editorial

  8. Published

    ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

    Simon Bach, 2020, In: Journal of Clinical Oncology . p. 4101-410 9 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2019
  10. Published

    Ibrutinib plus venetoclax in relapsed/refractory chronic lymphocytic leukemia: the CLARITY study

    Kristian Brock, Sam Munoz Vicente, Becky Boucher, 20 Oct 2019, In: Journal of Clinical Oncology . 37, 30, p. 2722-2729 8 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Trans-aTTom: Breast Cancer Index for prediction of endocrine benefit and late distant recurrence (DR) in patients with HR+ breast cancer treated in the adjuvant tamoxifen—To offer more? (aTTom) trial.

    Ikhlaaq Ahmed, Sarah Pirrie & Daniel Rea, 20 May 2019, In: Journal of Clinical Oncology. 37, 15_suppl, p. 505 1 p.

    Research output: Contribution to journal › Abstract › peer-review

  12. Published

    Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia

    Charles Craddock, Daniel Slade, Carmela De Santo, Rachel Hoare, Kristian Brock & Christina Yap, 1 Mar 2019, In: Journal of Clinical Oncology . 37, 7, p. 580-588 9 p., JCO1800889.

    Research output: Contribution to journal › Article › peer-review

  13. Published

    High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008

    & 22 others, , Keith Wheatley, 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.

    Research output: Contribution to journal › Article › peer-review

  14. 2018
  15. E-pub ahead of print

    High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008

    6 Sep 2018, (E-pub ahead of print) In: Journal of Clinical Oncology . 16 p.

    Research output: Contribution to journal › Article › peer-review

  16. E-pub ahead of print

    Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

    Keith Wheatley, 28 Aug 2018, (E-pub ahead of print) In: Journal of Clinical Oncology .

    Research output: Contribution to journal › Article › peer-review

  17. E-pub ahead of print

    Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review

    Raoul Reulen, 6 Jun 2018, (E-pub ahead of print) In: Journal of Clinical Oncology . 36, 9 p.

    Research output: Contribution to journal › Article › peer-review

  18. E-pub ahead of print

    Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer

    Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, (E-pub ahead of print) In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049

    Research output: Contribution to journal › Abstract › peer-review

  19. Published

    Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations

    Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.

    Research output: Contribution to journal › Article › peer-review

  20. Published

    Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial

    Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.

    Research output: Contribution to journal › Article › peer-review

  21. Published

    Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    & 12 others, , Daniel Rea, 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journal › Article › peer-review

  22. Published

    Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)

    9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.

    Research output: Contribution to journal › Abstract › peer-review

  23. 2017
  24. Published

    Improving outcomes in high-risk Myelodysplasia: Festina Lente

    Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812

    Research output: Contribution to journal › Editorial › peer-review

  25. E-pub ahead of print

    Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

    Gary Middleton, 27 Feb 2017, (E-pub ahead of print) In: Journal of Clinical Oncology .

    Research output: Contribution to journal › Article › peer-review

  26. Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials

    20 Feb 2017, In: Journal of Clinical Oncology . 35, 6, p. 622-628 7 p.

    Research output: Contribution to journal › Article › peer-review

  27. Published

    Randomized prospective biomarker trial of ERCC1 for comparing platinum and nonplatinum therapy in advanced non-small-cell lung cancer: ERCC1 Trial (ET)

    Gary Middleton, David Ferry & 3 others, , 1 Feb 2017, In: Journal of Clinical Oncology . 35, 4, p. 402-411 10 p.

    Research output: Contribution to journal › Article › peer-review

  28. 2016
  29. Published

    Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study

    Raoul Reulen, Emma Lancashire & Michael Hawkins, 20 May 2016, In: Journal of Clinical Oncology . 34, 15, p. 1772-1779

    Research output: Contribution to journal › Article › peer-review

  30. 2015
  31. Published

    Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: a phase III, randomized, double-blind, placebo-controlled study

    Hisham Mehanna & 5 others, , 10 Dec 2015, In: Journal of Clinical Oncology . 33, 35, p. 4202-4209

    Research output: Contribution to journal › Article › peer-review

  32. Published

    Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

    Charles Craddock, 1 Oct 2015, In: Journal of Clinical Oncology . 33, 28, p. 3144-3151 10 p.

    Research output: Contribution to journal › Article › peer-review

  33. Published

    Collaborative Research in Childhood Cancer Survivorship: The Current Landscape

    Michael Hawkins, 20 Sep 2015, In: Journal of Clinical Oncology . 33, 27, p. 3055-3064 10 p.

    Research output: Contribution to journal › Review article › peer-review

  34. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journal › Article › peer-review

  35. Published

    Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

    Rich Fox, 20 Feb 2015, Journal of Clinical Oncology , 33, 6, p. 550 558 p.

    Research output: Contribution to specialist publication › Article

  36. 2014
  37. Published

    Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

    Daniel Rea, 20 Sep 2014, In: Journal of Clinical Oncology. 32, 27, p. 2951-2958

    Research output: Contribution to journal › Article › peer-review

  38. Published

    Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial

    Keith Wheatley, 10 Aug 2014, In: Journal of Clinical Oncology . 32, 23, p. 2440-8 9 p.

    Research output: Contribution to journal › Article › peer-review

  39. Published

    Predictive importance of ulceration on the efficacy of adjuvant interferon-a (IFN): An individual patient data (IPD) meta-analysis of 15 randomized trials in more than 7,500 melanoma patients (pts).

    Natalie Rowland & Keith Wheatley, 20 May 2014, In: Journal of Clinical Oncology . 32, 15_suppl, 9067.

    Research output: Contribution to journal › Article › peer-review

  40. Published

    Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

    Claire Palles & 24 others, , David Kerr & Ian Tomlinson, 1 Apr 2014, In: Journal of Clinical Oncology . 32, 10, p. 1031-1039 9 p.

    Research output: Contribution to journal › Article › peer-review

  41. 2013
  42. Published

    Reply to K.I. Pritchard

    Daniel Rea, 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.

    Research output: Contribution to journal › Article › peer-review

  43. Published

    Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia

    Sylvie Freeman, Robert Hills, Nov 2013, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article › peer-review

  44. Published

    Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial

    Robert Hills, Keith Wheatley, 20 Sep 2013, In: Journal of Clinical Oncology . 31, 27, p. 3360-8 9 p.

    Research output: Contribution to journal › Article › peer-review

  45. Published

    Is uterine serous carcinoma a part of hereditary breast cancer syndrome

    Sudha Sundar, 10 Sep 2013, In: Journal of Clinical Oncology . 31, 26

    Research output: Contribution to journal › Article › peer-review

  46. Published

    Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

    Mark Drayson, 10 Jul 2013, In: Journal of Clinical Oncology . 31, 20, p. 2540-7 8 p.

    Research output: Contribution to journal › Article › peer-review

  47. Published

    Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.

    Pamela Kearns, 1 Jul 2013, In: Journal of Clinical Oncology . 31, 19, p. 2460-2468 9 p.

    Research output: Contribution to journal › Article › peer-review

  48. Published

    Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747)

    Lucinda Billingham, Stuart Collins, Emilio Porfiri, 20 Jun 2013, In: Journal of Clinical Oncology . 31, 18_suppl, p. LBA5000

    Research output: Contribution to journal › Article › peer-review

  49. Published

    Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis

    Daniel Rea, 20 Jun 2013, In: Journal of Clinical Oncology. 31, 18, p. 2257-2264 8 p.

    Research output: Contribution to journal › Article › peer-review

  50. Published

    Use of serum markers in prediction of survival in the trapeze factorial trial evaluating docetaxel with zoledronic acid, strontium-89, or both in castrate-refractory prostate cancer (CRPC) metastatic to bone

    Kaisheng Wen, Sarah Pirrie & Nicholas James, 3 Jun 2013, In: Journal of Clinical Oncology . 31 (supplement), suppl; abstr 5057.

    Research output: Contribution to journal › Abstract › peer-review

  51. Published

    Impact of gender on efficacy and acute toxicity in standard risk localized (SR) Ewing sarcomas (ES) in the Euro-Ewing99-R1 trial

    Keith Wheatley, 20 May 2013, In: Journal of Clinical Oncology . 31, suppl 15, abstr 10031.

    Research output: Contribution to journal › Article › peer-review

  52. Published

    Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission

    Robert Hills, Keith Wheatley, 1 Apr 2013, In: Journal of Clinical Oncology . 31, 10, p. 1293-301 9 p.

    Research output: Contribution to journal › Article › peer-review

  53. Published

    Muscle invasive bladder cancer in the elderly: Treatment and prognosis in a prospective cohort study

    Tom Wright, Adam Devall, Sarah Pirrie, Lucinda Billingham, KK Cheng, Rik Bryan, 20 Feb 2013, In: Journal of Clinical Oncology . 31, 6_suppl, p. 275

    Research output: Contribution to journal › Article › peer-review

  54. Published

    Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenstrom Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

    Dickens Pratt & 1 others, , 20 Jan 2013, In: Journal of Clinical Oncology. 31, 3, p. 301-307

    Research output: Contribution to journal › Article › peer-review

  55. 2012
  56. Published

    Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study

    Daniel Rea, 20 Dec 2012, In: Journal of Clinical Oncology . 30, 36, p. 4477-84 8 p.

    Research output: Contribution to journal › Article › peer-review

  57. Published

    Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia

    Robert Hills, Sylvie Freeman, Charles Craddock, Keith Wheatley, 2012, In: Journal of Clinical Oncology . 30, 32, p. 3924-31 8 p.

    Research output: Contribution to journal › Article › peer-review

  58. Published

    Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

    Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.

    Research output: Contribution to journal › Article › peer-review

  59. 2011
  60. Published

    Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer.

    Richard Gray, Kelly Handley, Laura Magill, 7 Nov 2011, In: Journal of Clinical Oncology.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next